Global disruption, drug shortages, geopolitical risk, and cost pressures have pushed pharma supply chains into the spotlight. What was once an operational function is now a direct driver of revenue, launch success, and investor confidence. Pharmaceutical Executive® sat down with Rafael Lander, Principal, Pharmaceutical & Life Sciences Supply Chain and Operations at PwC US, to explore how leading pharma and biotech organizations are modernizing their supply chains to improve resilience, accelerate launches, and protect margins. This is all done without compromising compliance or patient service. From AI-enabled forecasting to digitally connected quality operations, this conversation covers what is delivering results today and where executives should place their focus.
Key Objectives:
